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Abstract
Background: Previous studies have demonstrated that seven transmembrane receptors (7TM-Rs) can associate
with various chaperones to control their maturation and export. It has been shown for a few years now that 7TM-
Rs can form homo or heterooligomeric complexes. Due to the difficulty to study heterooligomers in a context
devoid of homooligomers signaling, very little is known on heterooligomerization. b2AR-AT1R receptor complexes
have been found on cells and ligand activation of one receptor affects signaling of the partner. Yet, very little is
known about the mechanisms linking those receptors together. We propose to examine the role of chaperones in
the maturation of homo- and heterodimers of the b2AR and AT1R. It would not be surprising that strict cellular
mechanisms exist to ensure that only properly folded receptors are inserted into the plasma membrane.
Results: Our goal is to understand the process whereby the adrenergic and angiotensin receptors attain their
proper mature conformation. We determined whether any of the common chaperones are physically associated
with the fully and/or immature b2AR and AT1R receptors forms and if they play any role in the selective
recruitment of G proteins subunits to receptor complexes. Our results suggest that when a pair of receptors is
expressed in such way that one is retained in the endoplasmic reticulum (ER), this immature receptor will dictate
the chaperones interacting with the receptor complex. We showed that ERp57 is important for receptor
dimerization of AT1R homo and b2AR/AT1R receptor dimers, but plays no role in the b2AR homodimerization.
Then, we verified if some of those chaperones could play a role in the assembly of the heterotrimeric G protein
subunits with the receptor complex, but none appeared to be essential.
Conclusions: Overall, our results suggest that variations among receptor oligomers occur early in the synthesis/
maturation processes, and that chaperones will interact more specifically with some receptor pairs than others to
allow the formation of certain receptor pairs, while others will contribute to the folding and maturation of
receptors without any effect on receptor assembly within a signaling complex.
Background
Seven transmembrane receptors (7TM-Rs) are the
largest family of plasma membrane receptors and couple
to G proteins to activate downstream signaling pathways
that give rise to alterations in cell function and gene
expression [1]. These receptors had traditionally been
thought to exist as monomers, but it is now known that
7TM-Rs exist as homo- and heterooligomers [2,3].
Heteromerization of receptors is an exciting new field in
pharmacology. It is possible that drugs that act on one
receptor in a heteromer might influence the signal
transduction mechanisms activated by the other recep-
tor. AT1R undergoes homo- and heterodimerize with
many other receptors, including bradykinin B2, b2-adre-
nergic and dopamine D2 receptors [4-7]. Until recently,
the functional consequence of heterodimerization had
not been described and its functional significance was
questioned. Now, examples of heterodimerization show
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that this phenomenon is clinically relevant and should
be taken into account during therapy. For example, het-
erodimerization of prostaglandin EP1 receptors with
b2ARs [8] showed that where EP1 receptors do not
appear to significantly affect airway tone, it was able
reduce the bronchodilatory function of b2-ARs. The
functional significance of 7TM-R heterodimers has also
recently been demonstrated in vivo for opioid receptors,
for which a heterodimer-selective agonist was described,
consistent with the hypothesis that these complexes
occur in native tissues [9]. Interestingly, it is known that
AT1Rs heterodimerize with many other receptors,
including b2ARs, where it was also demonstrated that
blockade of one of the two receptors in complex was
enough to inhibit signaling and trafficking of both
receptors. Treatment of murine myocytes with a b
blocker completely obliterated Angiotensin receptor/Gq
coupling and contractility, and treatment of mice with a
selective angiotensin receptor blocker attenuated heart
rate response to a b agonist [7].
Effects like this could contribute to the adverse effects
reported in Congestive Heart Failure patients taking a
combinatorial therapy including AT1R blockers and
bAR blockers [10]. However, little is known about the
formation of receptor heterodimers and the factors that
are important in the formation of AT1R/b2AR heterodi-
mers have not been established. Precise characterization
of receptor-mediated signaling pathways will be crucial
for the development of new therapeutic targets outside
the receptor-ligand interface. Drugs aimed at the ligand
binding site of 7TM-Rs that are coupled to multiple
effectors obviously lack specificity and activate many dif-
ferent effector routes. This can activate multiple signal-
ing pathways and generate unwanted side effects.
However, the presence of unique signaling partners
within a particular pathway (for example, G proteins
with a specific subunit composition, chaperones or
other regulatory molecules, GTPases, scaffolds or effec-
tors) suggests that there are unique structural compo-
nents that govern interactions between these proteins.
Previous studies have demonstrated that non-glycosy-
lated immature AT1R can associate with chaperones
such as calnexin and HSP70, while ER mannosidase I
participates in the acquisition of mature glycoforms of
the AT1R [11]. AT1R can also interact with DRiP78, a
DnaJ family protein known to retain proteins by mask-
ing ER-export sites before they are fully folded and
ready to be sent to the plasma membrane [12]. In con-
trast, very little is known about the chaperones which
interact with the b2AR. Recently, it was demonstrated
that DRiP78, a DnaJ class chaperone, could interact with
the b2AR and the Gg subunit of the G protein [13]. It is
possible that DRiP78 and other chaperones are involved
in the formation of b2AR/AT1R receptor complexes.
We propose to examine the role of chaperones in the
maturation of homo- and heterodimers of the b2AR and
AT1R. Due to the complex structure and organization
of these receptors, it is not altogether surprising that
strict cellular mechanisms exist to ensure that only
properly folded receptors are inserted into the plasma
membrane. 7TM-Rs are known to undergo multiple
steps of folding and posttranslational modifications
including N- and O-glycosylation, disulfide bonds and
palmitoylation which are regulated by yet undetermined
chaperones. Yet, it is not clear which chaperones might
be involved in the processing of 7-TMRs such as the
b2AR and AT1R. Our goal is to understand the process
whereby the adrenergic and angiotensin receptors attain
their proper mature conformation and to determine
how these receptors are assembled into homo and het-
erodimeric receptors. In these experiments, we will
determine whether any of the commonly used protein-
folding chaperones are physically associated with the
fully and/or immature b2AR and AT1R receptors forms
and if they play any role in the selective recruitment of
G proteins subunits to receptor complexes.
Results and Discussion
7TM-Rs are known to undergo multiple steps of folding
and post-translational modifications including N- and O-
glycosylation, disulfide bonds and palmitoylation which
allows proper expression and functions of receptors.
These steps are highly regulated and occur before recep-
tors are exported to plasma membrane. The overall pro-
cesses regulating 7TM-R exit from the ER and trafficking
to plasma membrane are not very well known. In recent
years, some studies have started to address the key issues
on how receptors traffic to plasma membrane, and how
they are assembled into signaling complexes [14]. Some
chaperones have been shown to play an important role in
the folding and assembly of different members of the
GPCR signaling complex [13,15,16]. While previous stu-
dies have demonstrated that non-glycosylated immature
AT1R can associate with various chaperones, it is not
clear which ones might be involved in the assembly of 7-
TMRs into signaling complexes; if any could be impor-
tant in the formation of receptor oligomers, or assembly
of the receptor with its cognate G protein and therefore
contribute to signaling specificity of receptor complexes.
BiFC Visualization of 7-TMRs homo and heterodimers
The study of heterodimeric receptors is still in its infancy,
given the difficulty of studying those receptors without the
background of homodimers expressed in the same cells.
Up to now, most studies revealing interactions between
receptors was done via co-immunoprecipitation or via
fluorescence based protein-protein interaction techniques
such as Fluorescence Resonance Energy Transfer (FRET)
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or Bioluminescence Resonance Energy Transfer (BRET).
Here, we used another fluorescence based technique,
Bimolecular Fluorescence complementation (BiFC), as a
tool to obtain a fluorescence signal when two receptors
dimerize. The advantage of using this technique is that it
allows another fluorescent- or bioluminescent-tagged pro-
tein to be used in FRET or BRET, therefore allowing to
monitor the specific interaction of a given combination of
receptor pair with other signaling partners. To do so, we
tagged our b2-adrenergic and angiotensin II AT1 recep-
tors with the first 157 amino acids of venus, a YFP variant,
or with the 158-238 remaining amino acids of venus (Fig-
ure 1a). As previously described for BiFC [17], expression
of each construction individually does not produce fluor-
escence, while expression of both halves, when paired to
interacting proteins, will generate a functional fluorescent
protein.
In order to visualize the expression of the different
receptor pairs, we performed imaging where HEK293
cells were transfected with the indicated receptor pairs in
Additional file 1: figure S1 (a-k). 48 hours after transfec-
tion, the slides were fixed with 3% paraformaldehyde for
20 mins and then fixed on cover slips. Upon receptor
dimerization, the venus molecule reconstitutes and emit
fluorescence at 525 nm when excited at 488 nm. The
first three figures (a-c) show the expression of wild type
receptor pairs that are either in a homodimer arrange-
ment (AT1R and b2AR or in the heterodimer form
AT1R/b2AR). As illustrated, the receptors are expressed
at the plasma membrane and they are lining the surface
of the cell. In contrast, when at least one of the receptors
in the dimer is immature i.e. has a mutation at the glyco-
sylation sites, the receptors are retained inside the cell.
Figure 1(d-j) shows that the strong fluorescence signal is
mainly concentrated in the endoplasmic reticulum region
which indicates that the trafficking of mutant receptors
to the plasma membrane is abolished. In addition, these
immature receptors prevent the wild type forms from
being expressed at the plasma membrane as well. This is
consistent with the results obtained with the dopamine
D2 receptor [18], CCR5 chemokine receptor [19] and
Vasopressin V2 receptor [20] where co expressing a
mutant receptor with the wild type form resulted in the
blockade of cell surface expression of the dimer. Figure
(1k and 1l) show intracellular localization of receptor
pairs expressing a receptor mutated in the FX(6)LL motif.
Our results confirm the intracellular retention of such
mutated receptors, and that such mutation prevents
export of WT receptors to plasma membrane as well.
Chaperone interaction with 7TM-Rs homo and
heterodimers
Interactions with ER-resident folding factors begin typi-
cally, as growing nascent chains enter the ER lumen
through the translocon complex and continue until the
newly synthesized protein is fully folded and assembled.
It is known that chaperones function to assist other pro-
teins to achieve proper folding [21-26]. The rules that
direct the selection of the different chaperones required
for proper folding and assembly of newly synthesized
proteins are only very poorly understood. Different
groups of chaperones have been identified, each with a
particular mode of action: 1) A group of classical cha-
perones that include BiP and several glucose-related
proteins (GRPs) represent a bona fide chaperone class.
They stabilize newly synthesized polypeptides during
folding, prevent aggregation and mediate retention of
peptides in the ER and suppress formation of non-native
disulfide bonds [27]. 2) A second group of chaperones,
such as the lectins, have greater substrate specificity.
They are non-enzymatic sugar-binding proteins and are
represented in the ER by calnexin and calreticulin.
It has been suggested that all glycoproteins (such as
7TM receptors) interact with ER lectins in mammalian
cells [28]. 3) Other proteins with chaperone activity
directly increase the rate of peptide folding, such as the
peptidyl-prolyl isomerase family that facilitates the rota-
tion around peptidyl-prolyl bonds of nascent poplypep-
tides [29,30]. The folding catalysts also include enzymes
of the protein-disulfide isomerase (PDI) family, which
are responsible for the formation of disulfide bonds
[31-33]. The interplay between these different chaperone
classes will determine the processes involved in folding
each protein.
Very little is known about the chaperones which inter-
act with the b2AR. Here, we propose to determine which
chaperones are involved in the maturation of homo- and
heterodimers of the b2AR and AT1R. First, we co-
expressed the WT isoforms of b2AR and AT1R, each
tagged with a portion of venus, as previously demon-
strated in Figure 1. Hek293 cells were tested for the
expression of each chaperone tested (figure 1b) and Bip,
Calnexin, Calreticulin, ERp57, HSP70, PDI and GRP94
were all expressed. Then, we proceeded with immuno-
precipitation of those chaperones and immunoblot
against GFP, which would reveal only the functional
GFP, observed only upon dimerization of the GPCR
pairs. Receptors expressed with only a portion of the
venus would not be recognized by the anti-GFP antibody
we used (figure 1c). Figure 2 shows the interaction pat-
terns of previously mentioned chaperones with the
b2AR-venus1/AT1R-venus2 dimer (figure 2a), AT1R-ve-
nus1/AT1R-venus2 dimer (figure 2b) and b2AR-venus1/
b2AR-venus2 dimer (figure 2c). Although interactions
with calreticulin, PDI and GRP94 appear to be conserved
through all receptor pairs, differences in the interaction
pattern can be observed in the case of Bip, which inter-
acts only with the b2AR homodimer, ERp57 which
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Figure 1 Expression of the receptor dimer pairs. a) Schematic presentation of the constructs used in the experiments. Venus1 contains the
N- terminal end of the yellow fluorescent protein variant (venus) and represents the first 157 amino acids while venus2 contains the C- terminal
end of the protein and represents amino acids 158 to 238. b) HEK293 cells were harvested, washed and lysed with RIPA buffer. Samples were
then run on SDS-PAGE and Western analysis was performed using indicated chaperone antibodies (1:2000). c) Specificity of GFP antibody to
dimers was tested in HEK293 cells. The cells were transfected with AT1R-v1 or v2, b2AR-v1 or v2 and AT1R-v2 with b2AR-v1. 48 hours after
transfection, cells were lysed in RIPA buffer. Western analysis was performed using anti-GFP (1:2000) and indicate the presence of a yellow
fluorescent protein variant, venus. Results are representative of 3 independent experiments.
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interacts only with AT1R-containing dimers, and HSP70
which interacts weakly with both homodimers, but not
the heterodimer. A reason for the differences observed
for HSP70 interaction with both homodimers and not
the heterodimer might be related to some observations
made about heterooligomeric receptors. For example, a
heterodimeric receptor could couple to G- protein subu-
nits other than those recruited by the homodimers and
hence activates effectors differently. This was suggested
for the mu/delta opioid heterodimer where no sensitivity
to pertussis toxin was observed while the homodimers of
these receptors were sensitive to it [34]. This was also
illustrated for the chemokine receptors CCR5/CCR2 as
well where the heterodimer was shown to couple to Gq/
11, a subunit that does not interact with CCR5 homodi-
mer or CCR2 homodimer [35]. Our results might suggest
that very early on, during receptor maturation, begins the
differentiation of the receptor complex formation which
will lead to the variations in receptor signaling between
homo and heterooligomeric receptors. When doing the
co-immunoprecipitation, all culture plates transfected
with the same cDNAs were pooled together and then co-
immunoprecipitations were done with each anti-chaper-
one antibody. Figure 2d shows the expression of recep-
tors, demonstrating that we can achieve good expression
of the receptor complexes in HEK293 cells.
As show in additional file 1: figure S1, the co-expressed
WT receptor pairs follow the entire process of matura-
tion to be ultimately expressed at the plasma membrane.
We wanted to understand whether the interaction of
chaperones required fully mature receptors, or if the
chaperones would interact with receptors that lack some
glycosylation sites, which would prevent the receptors
from reaching plasma membrane. Here, we used AT1R
with mutations at sites N4, 176, 188 D and b2AR with
mutations at positions N 4, 15, 176Q to understand the
effect of those glycosylation sites on chaperone interac-
tions with the receptor dimers. Interestingly, some varia-
tions happen in the chaperone interaction pattern with
receptor dimers following expression of the glycosylation
mutated receptors (Figure 3). Striking examples include
the appearance of interaction of ERp57, calnexin with the
b2AR homodimer (figure 3c), which was absent upon
co-expression of WT receptors (figure 2c). Also, the
AT1R(WT)-v2 - β2AR(WT)-v1
AT1R(WT)-v1 - AT1R(WT)-v2
β2AR(WT)-v1 - β2AR(WT)-v2 
IP:                Bip       CANX        CALR     ERp57    HSP70     PDI      GRP94












































IB:     YFP variant venus(d)
Figure 2 Interaction of wild type receptor dimers with chaperones. HEK293 cells were transfected with AT1R (WT)-v1/v2 and b2AR (WT)-v1/
v2. After 48 hours, cells were harvested, washed, lysed with RIPA. This lysate was distributed into eight different microcentrifuge tubes and co-
immunoprecipitations were performed using the indicated chaperone antibody. a) AT1R/b2AR (WT) heterodimer, b) AT1R (WT) homodimer c)
b2AR (WT) homodimer. The eighth sample was loaded as a control to show the expression level of the wild type receptor dimers as shown in d.
Results are representative of 4 independent experiments.
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weak interaction of PDI with the b2AR dimer gained
strength with the non-glycosylated mutants. Those
results suggest that these chaperones are important for
the maturation into the glycosylated forms of the recep-
tor. Interestingly, Bip interaction was lost with the non-
glycosylated form of the b2AR. No change was observed
for any chaperone with the AT1R receptor homodimer,
or the b2AR/AT1R dimer. It appears that for those pairs,
the chaperone interaction profile follows the one needed
for AT1R, which might act as the dominant receptor of
the pair in terms of maturation.
We then moved to co-express receptor pairs where one
receptor would be able to fully mature (WT), with a part-
ner which would be glycosylation deficient, to see the
influence of receptors on each other’s maturation and cha-
perone interaction. We show in figure 4 (figure 4a, b, c,
and 4d) that the chaperone interaction pattern follows
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Figure 3 Interaction of immature receptor dimers with chaperones. HEK293 cells were transfected with AT1R (N4, 176, 188D)-v1/v2 and
b2AR (N 4, 15, 176Q)-v1/v2. After 48 hours, cells were harvested, washed, lysed with RIPA and precleared with protein A-sepharose beads. This
lysate was distributed into eight different microcentrifuge tubes and co-immunoprecipitations were performed using the indicated chaperone
antibody. a) AT1R (ND)/b2AR (NQ) heterodimer, b) AT1R (ND) homodimer, c) b2AR (NQ) homodimer. The eighth sample was loaded as a control
to show the expression level of the immature receptor dimers as shown in d. Results are representative of 4 independent experiments.
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mature receptor. Those results suggest that the least
mature receptor would retain the WT receptor inside the
cell as previously shown in the additional figure. This
would be logical since the effects of having an immature
receptor expressed at plasma membrane could have
important consequences on the signal transduction. Figure
4 rows e and f show the influence of a mutant of AT1R
which is retained in the ER (AT1Rm), but has no effect on
glycosylation. The mutation is in the F(X)6LL motif, where
the F and LL are mutated to alanine. This motif has been
shown to be important for export from the ER for several
receptors [36,37]. Again, the least mature receptor dictates
the interaction pattern with chaperones, as observed in
rows 4e and 4f, where the ER-retained receptor AT1Rm/
AT1R WT pair has the same interaction pattern as the
AT1Rm/AT1Rm pair. Interestingly, with the AT1Rm, all
IP:          Bip         CANX       CALR       ERp57    HSP70        PDI         GRP94
IB:     YFP variant venus
AT1R(WT)-v2 - β2AR (NQ)-v1
AT1R(ND)-v2  - β2AR (WT)-v1
AT1R(ND)-v1  - AT1R (WT)-v2



























































































(g) IB:  YFP variant venus
Figure 4 Immature receptors dictate dimers interaction with chaperones. HEK293 cells were transfected with AT1R (WT or ND)-v1/v2 and
b2AR (WT or NQ)-v1/v2. After 48 hours, cells were harvested, washed, lysed with RIPA and precleared with protein A-sepharose beads. The lysate
was distributed into eight different microcentrifuge tubes and co-immunoprecipitations were performed using the indicated chaperone
antibody. The eighth sample was loaded as a control to show the expression level of the different receptor dimers as shown in g. Results are
representative of 4 independent experiments.
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chaperones tested show some level of interaction with the
receptor complex. Since this is a receptor mutation that
would not be able to be changed by chaperone interven-
tion, there is most likely a complete blockade of the
maturation pathway which would result in receptor dimer
interaction with chaperones at each step of the pathway.
This could explain the interaction with all chaperones,
assuming that their actions do not occur all at once on the
receptor, but rather more or less consecutively as literature
suggests. Figure 4g shows that all receptor pairs could be
recognized by our anti-GFP antibody.
Effect of Chaperones on WT receptor dimerization
It is already known that several chaperones are required
for the assembly of different protein complexes. For
example, Phosducin-like protein (PhLP) and dopamine
receptor interacting protein 78 (DRiP78) were shown to
form a complex in order to assemble the Gbg subunits
of the G protein [15,16,38]. In other cases, chaperones
were able to interact with channels, but played no role
in the proper assembly and folding of the channel. One
example would be calnexin, which interacted transiently
with wild-type Shaker protein in the ER but, failed to
associate with an unglycosylated Shaker mutant that
makes active, cell surface channels. Glycosylation of
Shaker protein was required for association with cal-
nexin, but was not required for the proper folding and
assembly of Shaker channels [39]. Here, we tested the
effect of chaperones on receptor dimerization. In order
to obtain a functional venus, which is able to produce
fluorescence, the receptor dimers needs to be assembled.
We co-expressed different chaperone WT or mutants
constructs (Bip WT or T37G), or inhibitory RNA to
observe the effects of chaperones on fluorescence forma-
tion. We tested the effect of WT Bip, calnexin, GRP94
and ERp57 and none showed a significant modification
of the level of fluorescence observed (Figure 5 for Bip
and ERp57, data not shown for calnexin and GRP94).
We were intrigued to know if overexpressing a chaper-
one would promote the formation of dimers, which was
not the case for the chaperones tested. This suggests
that there probably already are sufficient levels of cha-
perones in the cell to deal with any increased demand








































Figure 5 The effect of Bip, HSP70 and ERp57 on receptor dimerization. HEK293 cells were transfected with WT AT1R-v1/v2 and b2AR-v1/v2.
After 48 hours, cells were harvested, washed with 1X PBS and resuspended in 100 μl PBS. Fluorescence was then measured using an EnVision
plate reader at 528 nm. Results are expressed as means ± sem of at least 3 experiments. * = p < 0.05; ** = p < 0.01 compared with negative
controls using two-tailed paired Student’s t test. Results are representative of 3 independent experiments.
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lowering the levels of functional chaperones expressed
with inhibitory RNA (Efficiency of inhibition shown in
additional file 2: Figure S2) or a mutated inactive form
of Bip. No change were observed with the Bip mutant
either. ERp57 shRNA co-expression with the b2AR
homodimer showed no difference, but significant
changes in fluorescence levels were observed upon co-
expression with the AT1R homodimer or with b2AR/
AT1R heterodimer. Such role for ERp57 wouldn’t be
exclusive for 7TM-Rs, as it was shown the MHC class I
receptors that a calnexin/ERp57 complex is thought to
facilitate the correct oxidation and folding of class I
heavy chains into a conformation compatible with
recognition by b2m [40].
Effect of Chaperones on G protein assembly with
receptors
It was shown that some chaperones have an effect on the
assembly of G proteins coupling to 7TM-Rs. Several stu-
dies have shown that a complex of chaperones, formed
by PhLP, the cytosolic chaperonin complex (CCT) would
interact with the beta subunit of the G protein, while
DRiP78 would interact with the gamma subunits of the
G protein prior they are assembled together [15,16,38].
Results showed, at least for DRiP78, that it stabilized Gg
before the stable interaction with Gb [38]. It was also
demonstrated that the G protein subunit could form a
complex with the receptor before it reaches plasma
membrane [14]. Here, we tested whether some of the
chaperones capable of interacting with the b2AR and
AT1R receptors could mediate the formation of the
receptor-G protein complex. We tested the effect of Bip,
calreticulin and ERp57 on the assembly of Ga subunits,
as well as the Gbg subunit with the receptors AT1R and
b2AR homodimers, and AT1R/b2AR heterodimer as
measured by Bioluminescence Resonance Energy Trans-
fer (BRET). Figure 6 shows results from the AT1R/b2AR
heterodimer (AT1R and b2AR homodimers results are
not shown) which suggests that none of the chaperones
tested actually have an effect on the assembly of the G
protein with the receptor dimers. We co-expressed along
with the venus-tagged receptor dimers the Galphas-Rluc
or Galphai-Rluc subunits, in presence of Gbeta1gamma2,
therefore forming a functional G protein with the recep-
tor pair. Then, cells were harvested and treated with coe-
lentrazine H and measurements of BRET signals were
taken. Signals of luciferase luminescence and fluores-
cence from venus were then used to make a BRET ratio.
The BRET ratio gives an indication of the interaction
between the different partners. No effect was observed
for the different chaperones tested (figure 6a and 6b).
The same experiment was repeated in absence of Galpha
subunits, as it was previously demonstrated that Gbg
could interact with the b2AR under such circumstances.
Again, none of the chaperones tested had a significant
impact on the BRET signal observed between the venus-
tagged receptor dimer and the Rluc-tagged G protein
subunits Rluc-Gb1 or Rluc-Gg2 (in presence of the
untagged other subunit to form a stable Gbg complex)
(figure 6c and 6d). Our results demonstrate that none of
the chaperones tested have an impact on the formation
of the G protein association with the receptor. Although
these chaperones have no impact, it doesn’t mean that
there wouldn’t be a contribution of chaperones in the
assembly of the receptor signaling complex. Proteins that
may be considered chaperones for G protein subunits
like Ga include the J domain-containing cysteine string
protein (CSP) [41], Ga-interacting vesicle-associated pro-
tein (GIV, also known as girdin), Daple, and FLJ000354
[42]. These proteins may be involved in assembling G
protein heterotrimers and may also represent potential
interacting proteins for PhLP-1 and/or DRiP78. The fact
that certain chaperones such as CSP and DRiP78 can
also interact with effector molecules [e.g., voltage-gated
calcium channels [43-45] or GPCRs (e.g., dopamine D1,
M2 muscarinic cholinergic, angiotensin II AT1 receptors
[12,46,47], and the b2AR [38]) suggests that these chaper-
ones may also be involved in the formation or trafficking
of specific receptor signaling complexes that include the
G protein heterotrimer. Overall, more work is needed to
fully understand the receptor signaling complex assembly
with its cognate G protein, and how specificity of signal
transduction can be attained.
Conclusions
Molecular chaperones are highly important for the
maturation and folding of signaling proteins such as
plasma membrane receptors and effectors. In this report,
we investigated the role of several chaperones that are
commonly found to interact with a variety of partners.
We show that not all chaperones will interact in a simi-
lar fashion with 7TM-R dimers, whether they are homo
or heterodimeric. Our results suggest that when a pair
of receptors is expressed in such way that one is
retained in the ER or not fully glycosylated, this imma-
ture receptor will dictate the chaperones interacting
with the receptor complex. We showed that ERp57 is
important for receptor dimerization of AT1R homo and
b2AR/AT1R receptor dimers, but plays no role in the
b2AR homodimerization. Then, we verified if some of
those chaperones could play a role in the assembly of
the heterotrimeric G protein subunits with the receptor
complex, but none appeared to be essential. Overall, our
results suggest that variations among receptor oligomers
occurs early in the synthesis/maturation processes, as
chaperones will interact more specifically with some
receptor pairs than others. We propose that other cha-
perones, potentially chaperones playing a more specific
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Figure 6 The effect of Bip, Calreticulin and ERp57 on G-protein assembly with the heterodimer. HEK293 cells were transfectedwith b2AR-
v1, AT1R-v2 and Rluc G-proteins (Gas, Gai, Gb1 and Gg2). 48 hours post transfection, cells were harvested, washed three times with PBS then
suspended in 100 μl PBS. 90 μl of the samples was distributed into 96 well plates and 10 μl of 5 μM coelenterazine H was added and mixed
then the fluorescence energy emitted by Rluc and YFP (venus) was measured at their corresponding emission wavelengths (460 and 528 nm,
respectively). The BRET ratio was then calculated and plotted with the ratios for a negative control (b2AR-v1, AT1R-v2 and the pRluc-N3 vector)
and a positive control (b2AR-Rluc and b2AR-EGFP). Results are expressed as means ± sem of at least 3 experiments. Statistical analysis was
performed using two-tailed paired Student’s t test.
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role, might act upon the receptor and G proteins to cre-
ate functional signaling complexes. Yet, no chaperone
has been demonstrated to play such role but their iden-
tification could provide new therapeutic targets to con-




Reagents were obtained from the following sources: fetal
bovine serum and Lipofectamine 2000 transfection
reagent were from Invitrogen (Etobicoke, ON, Canada);
Dulbecco’s modified Eagle’s medium high glucose and
all chemicals were obtained from Sigma-Aldrich (Oak-
ville, ON, Canada), unless noted. Bip, ERP57, calnexin,
calreticulin, HSP70, PDI and GRP94 antibodies were
purchased from Cedarlane Labs (ON, Canada) and poly-
clonal GFP antibodies were purchased from Santa Cruz
(Santa Cruz, CA, USA). Calreticulin and ERp57 inhibi-
tory RNAs were obtained from Applied BioSystems
(Carlsbad, California, USA). HSP70 inhibitory RNA was
purchased from Santa Cruz (Santa Cruz, CA, USA).
Constructs
All BRET constructs (controls, as well as G protein
subunits) were obtained from Dr. Terence E. Hébert
(McGill University). b2AR and AT1R F(X)6LL mutants
were obtained from Guangyu Wu (Lousiana State Uni-
versity Health Sciences Center) while AT1R ND-GFP
mutant was obtained from Dr. Gaétan Guillemette
(Université de Sherbrooke). AT1R N4,176,188 D
venus1 and AT1R N4,176,188 D venus2 were cloned
by amplifying AT1RND-GFP by PCR using AT1R ND
FWD primer (5′-AAGCTGCTAGCATTCTCGACT
CTTCTACTGAAGATGGT-3′) and AT1R RVS primer
(5′-GCCACCTTCGAACTCAACCTCAAAACATGG
TGCAGGCTT-3′). The PCR product was subcloned
into either pcDNA3.1 zip-venus1 or pcDNA3.1 venus2
vectors using NheI-ClaI/BstBI as the restriction sites.
b2AR N4, 15, 176Q amplified by PCR using b2AR
(NQ) FWD primer (5′-ATGTGCG GCCGCAC-
CATGGGGCAACCCGGGCA GGGC-3′) and b2AR
(NQ) RVS primer (5′-GCCACCATCGATCAGCAGT-
GAGTCATTTGT-3′) and subcloned into pcDNA3.1
vectors containing either zip-venus1 or venus2 using
NotI-ClaI sites.
Cell Culture and Transfections
HEK293 cells were grown in Dulbecco’s modified Eagle’s
medium high glucose supplemented with 10% fetal
bovine serum and transfected using Lipofectamine 2000
as per the manufacturer’s instructions. Cells were plated
in 6-well plates. Experiments were carried out 48 hours
after transfection.
Immunoprecipitation
48 hours after transfection into 100-mm2 dishes (for
these experiments 4 μg of each cDNA was transfected
into each dish, and total DNA levels/dish were kept
constant by adding pcDNA vector as required). Cells
were then washed with PBS and harvested. Cells expres-
sing the same cDNAs were pooled together and then
evenly distributed in microcentrifuge tubes for co-
immunoprecipitations. Samples were lysed in 0.8 ml of
radioimmune precipitation assay (RIPA) buffer (50 mM
Tris, pH 7.5, 10 mM MgCl2, 150 mM NaCl, 0.5%
sodium deoxycholate, 1% Nonidet P-40, 0.1% SDS,
Complete Protease inhibitors (Roche; Laval, QC,
Canada) and DNase I). The lysate was solubilized by
incubation at 4°C for 30 min, precleared with 50 μl of
protein A-Sepharose beads at 4°C for 1 h, and clarified
by centrifugation at 14,000 rpm for 10 min. Superna-
tants were then transferred into another microcentrifuge
tube and incubated with an antibody overnight. The
immunoprecipitated proteins were eluted from beads
with 50 μl of SDS sample buffer and resolved by SDS-
PAGE, and Western blots were performed as described
[48]. When immunoprecipitation was not required, cells
were lysed in 200 μl of RIPA buffer, precleared with
protein A-sepharose and then SDS-PAGE loading buffer
was added. Immunoblots were probed with either a
monoclonal anti-GFP antibody (1:1000) or monoclonal
anti-HA (Covance, 1:1000 dilution), Horseradish peroxi-
dase-conjugated secondary antibodies were also from
Santa Cruz (anti-mouse or anti-rabbit, 1:10,000).
Bimolecular Fluorescence Complementation (BiFC) and
Bioluminescence Resonance Energy Transfer (BRET)
HEK293 cells were co-transfected with vectors expressing
the GFP- and Rluc-fusion proteins (1 μg of each cDNA
was transfected into each well of a 6-well plate, and total
DNA/dish was kept constant by adding pcDNA vector as
required). 48 hours after transfection, cells were har-
vested and washed once with phosphate-buffered saline
(PBS). The cells were then suspended in PBS+ (PBS +
0.1% glucose) and distributed into 96-well microplates
(white Optiplate; Perkin-Elmer Life and Analytical
Sciences). Signals were collected on a Packard Fusion
instrument (Perkin- Elmer Life and Analytical Sciences)
using coelenterazine H as a substrate. Whether or not
BRET occurred was determined by calculating the ratio
of the light passed by the 450/58 (luciferase) and 535/25-
nm band pass filters (YFP) for BRET1. This ratio is
referred to as the BRET ratio. To avoid possible varia-
tions in the BRET signal resulting from fluctuation in the
relative expression levels of the energy donor and accep-
tor, we designed transfection conditions to maintain con-
stant GFP/Rluc expression ratios in each experimental
set. BiFC signals were determined by the measurement of
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the light that passed by the 535/25-nm band pass filters
(YFP). BRET background was determined under condi-
tions where resonance energy transfer between Rluc and
GFP either could not or did not occur. This was accom-
plished by expressing Rluc or Rluc-tagged proteins either
alone or together with GFP or GFP-tagged proteins, none
of which interact physiologically. The background was
the same regardless of which of the aforementioned indi-
vidual proteins or combinations of proteins were
expressed, and it has been subtracted to yield a BRET
Ratio.
Fluorescence Microscopy
Twenty four hours post-transfection, HEK 293 cells
were harvested and seeded on laminin-coated cover
slips for 4 h at 37°C. The cells were then fixed for 20
min in PBS, pH 7.4, containing 3% (w/v) paraformalde-
hyde. The cover slips were washed with PBS, drained,
and mounted onto glass slides using a drop of 0.4% 1,4-
diazabicyclo{2.2.2}octane/glycerol medium. Cover slips
were fixed to the slides with nail polish. Fluorescence
microscopy was performed with an Olympus IX81
equipped with a Photometrics coolSNAP HQ2 camera
and excite series 120Q light source. YFP (venus) was
excited at 488 nm, and image acquisition was done at
fluorescence emission 525 nm.
Additional material
Additional file 1: figure S1. Images a through l were obtained by
transfecting HEK293 cells with the indicated receptors and mounting the
cover slips on glass slides. Visualization was performed using an inverted
fluorescence microscope (Olympus IX81), a) AT1R-v1/AT1R-v2, b) b2AR-
v1/b2AR-v2, c) AT1R-v2/b2AR-v1, d)AT1R (ND)-v1/AT1R (ND)-v2, e) b2AR
(NQ)-v1/b2AR (NQ)-v2, f)AT1R (ND)-v2/b2AR (NQ)-v1, g) AT1R-v2/b2AR
(NQ)-v1, h)AT1R (ND)-v2/b2AR-v1, i)AT1R-v1/AT1R (ND)-v2, j) b2AR-v1/
b2AR (NQ)-v2, k)AT1Rm1-v1/AT1Rm1-v2, l)AT1R-v1/AT1Rm1-v2.
Additional file 2: figure S2. HEK293 cells transfected or not with HSP70
shRNA, calreticulin or ERp57 siRNAs were harvested 24 hours post-
transfection. Cells were then lysed in RIPA buffer and samples were
loaded on SDS-PAGE gel for analysis of the presence of each chaperone
in the lysate using the appropriate antibody recognizing the chaperone.
Results are representative of at least 3 experiments, each performed
individually.
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